DUTCH Test Longevity-Medicine Target Ranges: What Optimal Looks Like

What the DUTCH Test Actually Measures

The DUTCH test goes well beyond a serum hormone panel. Standard blood draws capture a single snapshot of total or free hormone levels. The DUTCH panel captures both the parent hormones and their downstream metabolites, giving clinicians a picture of how the body is actually processing and clearing each compound.

Precision Analytical, the Oregon-based laboratory that developed the DUTCH test, measures roughly 35 analytes from four to five timed dried-urine collections. These include free cortisol and free cortisone at multiple time points, total cortisol and cortisone metabolites (the THF, THE, and allo-THE fractions), DHEA and DHEA-S, testosterone and its 5α/5β-reduced metabolites, estrone, estradiol, estriol, and their phase-I hydroxylation products, progesterone metabolites (primarily pregnanediol glucuronide, or PDG), and melatonin as 6-sulfatoxymelatonin (6-OHMS). The organic acids section adds markers for B12-dependent methylation, oxidative stress (8-OHdG), and neurochemical turnover (homovanillic acid, vanilmandelic acid, 5-HIAA).

Why Dried Urine Outperforms Single Blood Draws for Metabolites

A serum estradiol result tells you circulating E2 level. It reveals nothing about whether that estradiol is being hydroxylated preferentially down the protective 2-OH pathway versus the potentially carcinogenic 16α-OH pathway. A 2018 review in the Journal of Steroid Biochemistry and Molecular Biology confirmed that urinary estrogen metabolite ratios predict breast cancer risk independently of circulating estradiol levels. [1]

Reference Range vs. Longevity Target Range

"Normal" on a standard reference range means the value falls within two standard deviations of the population mean. That population includes sedentary, sleep-deprived, metabolically unhealthy individuals. Longevity medicine sets targets based on the literature on biological age, all-cause mortality risk, and functional capacity, not population averages.

The Endocrine Society's 2023 clinical practice guideline on male hypogonadism states: "Clinicians should use assay-specific and population-specific reference ranges derived from healthy young men when interpreting testosterone results." [2] The same logic extends to every analyte on the DUTCH panel.

Cortisol and the HPA Axis: Longevity Targets

Cortisol is the most misread analyte on any hormone panel. A single morning serum cortisol tells you almost nothing about HPA axis rhythm. The DUTCH panel gives you free cortisol at waking, 30 minutes post-waking, afternoon, and bedtime, plus total metabolized cortisol output across the day.

Cortisol Awakening Response

The cortisol awakening response (CAR) is the 50 to 160% rise in cortisol that occurs in the 20 to 30 minutes after waking. Research published in Psychoneuroendocrinology found that a blunted CAR correlates with burnout, chronic fatigue, immune dysregulation, and accelerated biological aging. [3] For longevity optimization, the HealthRX medical team targets a CAR ratio of 2.5 to 3.5× the pre-waking sample.

A flat CAR (ratio <1.5) warrants investigation for sleep disorders, chronic stress-induced HPA suppression, or subclinical adrenal insufficiency before any hormone therapy is started or continued.

Total Cortisol Output and Metabolite Pattern

Total metabolized cortisol (the sum of THF + allo-THF + THE fractions) reflects integrated 24-hour output. Values persistently in the upper quartile of reference range, combined with a preserved diurnal slope, are associated with maintained metabolic flexibility. A 2021 analysis in JCEM linked higher 24-hour urinary cortisol to increased all-cause mortality only when accompanied by loss of diurnal rhythm, not when the pattern remained intact. [4]

The 5α/5β metabolite ratio matters too. A ratio skewed toward 5α-reduced metabolites (androsterone relative to etiocholanolone) suggests increased 5α-reductase activity, which can drive androgenic side effects in women on DHEA or testosterone therapy.

Cortisone to Cortisol Balance

The ratio of free cortisone to free cortisol on the DUTCH panel reflects 11β-HSD2 enzyme activity. Chronically elevated cortisone relative to cortisol may indicate compensatory down-regulation of cortisol in peripheral tissues, which is one mechanism proposed for why chronic psychological stress degrades tissue-level cortisol signaling even when serum levels appear normal.

DHEA and Its Metabolites

DHEA is the most abundant steroid hormone in the human body and one of the strongest longevity biomarkers in the epidemiological literature.

Why DHEA Declines Matter

The Baltimore Longitudinal Study of Aging found that DHEA-S peaks around age 25 and falls approximately 2% per year thereafter, reaching roughly 10 to 20% of peak values by age 70. [5] Low DHEA-S has been prospectively associated with cardiovascular mortality, reduced insulin sensitivity, loss of lean mass, and cognitive decline across multiple cohort studies.

A NEJM randomized trial of DHEA replacement in adrenal insufficiency (N=39) demonstrated improved well-being scores, bone mineral density preservation, and androgen restoration at doses of 50 mg/day. [6]

Longevity Target for DHEA-S

On the DUTCH panel, DHEA and DHEA-S are reported. The longevity-medicine target mirrors a biological age of 30 to 35, regardless of chronological age. Approximate serum DHEA-S equivalents:

• Women: 200 to 350 mcg/dL
• Men: 300 to 500 mcg/dL

These correspond to upper-third values for the 30 to 39-year age bracket in the NHANES III reference dataset. Clinicians must calibrate DUTCH DHEA output values against the lab's own age-matched percentile tables and aim for the 60th, 85th percentile of the 30 to 39 reference cohort.

Sex Hormone Metabolites: Estrogen Pathways

Estrogen metabolism is arguably the highest-value section of the DUTCH panel for cancer risk stratification and HRT monitoring.

The Three Hydroxylation Pathways

Estradiol is hydroxylated primarily via three routes:

1. 2-OH pathway (CYP1A1/CYP1A2): produces 2-hydroxyestrone (2-OHE1), considered the "protective" metabolite.
2. 4-OH pathway (CYP1B1): produces 4-hydroxyestrone (4-OHE1), which can form DNA adducts and is considered genotoxic at elevated levels.
3. 16α-OH pathway (CYP3A4): produces 16α-hydroxyestrone (16α-OHE1), associated with estrogenic proliferative signaling.

A landmark study in Cancer Epidemiology, Biomarkers and Prevention (Muti et al., N=10,786 in the EURAMIC/ORDET cohort) found that women with a 2-OHE1 to 16α-OHE1 ratio above 2.0 had a significantly lower breast cancer incidence over a 5.5-year follow-up. [7]

Optimal Estrogen Metabolite Targets

For longevity optimization, the HealthRX medical team uses these thresholds based on the available literature:

• 2-OHE1 / 16α-OHE1 ratio: >2.0 (aim for 2.0 to 4.0)
• 4-OHE1 level: Below the 50th percentile of age-matched reference range
• Estradiol (E2) output: Consistent with pre-menopausal mid-follicular phase in women on HRT (mid-range of luteal phase for cycle optimization)
• Estrone (E1) / estradiol (E2) ratio: <2.0 in post-menopausal women on HRT, since a high E1-dominant state correlates with inferior symptom control and potentially higher proliferative risk

Dietary interventions that shift the 2/16 ratio favorably include cruciferous vegetable intake (indole-3-carbinol) and avoidance of excess alcohol, which upregulates CYP3A4 and pushes metabolism toward 16α-OHE1.

Methylation of Estrogen Metabolites

The DUTCH panel also reports 2-methoxyestrone (2-MeO-E1), the COMT-methylated product of 2-OHE1. Adequate methylation is protective because it neutralizes the reactive quinone intermediates that the 4-OH pathway generates. Low 2-MeO-E1 relative to 2-OHE1 suggests COMT enzyme under-activity or inadequate methyl donor availability (folate, B12, magnesium).

Testosterone and Androgenic Metabolites

The DUTCH panel does not directly replace serum total testosterone or SHBG, but it adds critical metabolite data unavailable from blood testing.

Androsterone and Etiocholanolone

These two 17-ketosteroid metabolites reflect downstream androgen clearance. Their ratio (androsterone/etiocholanolone) indicates the relative activity of 5α-reductase versus 5β-reductase. High 5α activity in women on testosterone therapy predicts scalp hair loss and acne before those symptoms manifest clinically, giving a 6 to 8 week window for dose adjustment.

For men on TRT, longitudinal DUTCH monitoring allows dose titration to maintain testosterone metabolites in the upper third of the age 30 to 35 reference range while confirming that DHT (5α-dihydrotestosterone metabolites) stays within the upper-normal zone rather than pushing into supraphysiological territory, which a 2020 JAMA Internal Medicine meta-analysis linked to polycythemia and cardiovascular risk at high doses. [8]

Progesterone Metabolites (PDG)

Pregnanediol glucuronide (PDG) is the primary urinary metabolite of progesterone. It is reported per milligram of creatinine to adjust for hydration.

Mid-luteal PDG below 5 mcg/mg creatinine is consistent with anovulatory cycles or luteal phase deficiency even when serum progesterone appears adequate on a single draw. For longevity optimization in cycling women, the HealthRX target is >7 mcg/mg creatinine at the luteal peak, corresponding to strong ovulatory function. Women on oral micronized progesterone (Prometrium) show elevated PDG (often >100 mcg/mg creatinine) due to gut/hepatic conversion, while those on vaginal or topical progesterone will show lower PDG with higher serum levels. This distinction is critical for interpreting results.

The American College of Obstetricians and Gynecologists' Practice Bulletin on menopause management notes that "progesterone protects the endometrium from estrogen-induced hyperplasia and should be used in any woman with a uterus who is receiving systemic estrogen." [9]

Melatonin (6-OHMS) as a Longevity Biomarker

Melatonin has direct antioxidant properties beyond its role in sleep regulation. Urinary 6-sulfatoxymelatonin (6-OHMS) on the DUTCH panel reflects the prior night's total melatonin secretion.

A 2020 cohort study in JNCI (N=22,067) found that higher urinary 6-OHMS was associated with a 39% lower risk of lethal prostate cancer in men. [10] For women, melatonin suppression from light exposure has been linked in observational data to higher breast cancer incidence.

Longevity target: 6-OHMS >40 ng/mg creatinine on the overnight void. Values below 20 ng/mg creatinine warrant investigation of sleep hygiene, nighttime light exposure, and potential exogenous melatonin supplementation (0.5 to 1 mg physiological dosing rather than the 5 to 10 mg supraphysiological doses common in retail products).

Organic Acids Section: Methylation and Oxidative Stress Markers

Many DUTCH panels include an organic acids add-on that reports:

8-OHdG (Oxidative DNA Damage)

8-hydroxy-2-deoxyguanosine is a direct marker of oxidative DNA damage. A 2019 meta-analysis in Free Radical Biology and Medicine found that urinary 8-OHdG predicts all-cause mortality with a pooled hazard ratio of 1.22 per standard deviation increase (95% CI: 1.11 to 1.35, P<0.001). [11] Longevity target: below the 50th percentile of the age-matched reference range.

B12-Dependent Methylation Markers

Methylmalonic acid (MMA) and methylcitric acid reflect B12 and biotin sufficiency respectively. Even serum B12 within reference range can coexist with functional intracellular deficiency. Elevated MMA with normal serum B12 warrants methylcobalamin supplementation or injection, given B12's central role in COMT methylation of catechol estrogens.

Neurotransmitter Metabolites

Homovanillic acid (HVA) and vanilmandelic acid (VMA) reflect dopamine and norepinephrine turnover. 5-HIAA reflects serotonin turnover. These are not primary longevity biomarkers on the DUTCH panel, but they can reveal why patients report fatigue, mood instability, or poor stress resilience despite hormone levels that look adequate on paper.

How to Use DUTCH Results in a Longevity Protocol

Interpreting the DUTCH panel requires a four-step clinical framework.

Step 1: Assess the diurnal cortisol pattern first. No hormone optimization is effective on top of a dysregulated HPA axis. Blunted CAR or absent diurnal slope must be addressed before adding testosterone, thyroid, or DHEA.

Step 2: Evaluate total hormone output against longevity targets, not just standard reference ranges. A 58-year-old man with testosterone metabolites at the 20th percentile of his age bracket is in range by conventional standards but well below the longevity target of the upper third of the 30 to 35-year reference cohort.

Step 3: Examine metabolite ratios, not just parent hormone levels. High estradiol with a favorable 2/16 ratio and adequate methylation carries a different risk profile than the same estradiol level with a suppressed 2/16 ratio and low 2-MeO-E1.

Step 4: Retest at 3 months after any intervention. Dietary changes (cruciferous vegetables, alcohol reduction) and supplementation (DIM, calcium-D-glucarate, methylated B vitamins) shift estrogen metabolite ratios within 6 to 12 weeks. Hormone dose adjustments show full metabolite stabilization by 8 to 10 weeks. The standard HealthRX retest interval is 90 days.

Monitoring DUTCH Results During Hormone Therapy

DUTCH testing during HRT or TRT provides information that serum panels cannot.

For women on topical or transdermal estradiol, serum E2 levels are notoriously variable. DUTCH urinary estradiol metabolites provide a more stable integrated measure of tissue exposure. A position statement from the Menopause Society (NAMS), updated in 2023, supports individualized hormone monitoring using clinical symptoms alongside laboratory data, though it does not yet endorse a specific testing modality for routine monitoring. [12]

For men on testosterone cypionate or enanthate, combining DUTCH with standard serum testosterone and hematocrit monitoring at 8 to 12 weeks post-dose change gives a complete picture of androgenic metabolite load and estrogen conversion. Aromatase activity shows up in the DUTCH panel as elevated estradiol and estrone metabolites relative to testosterone metabolites, identifying candidates for low-dose aromatase inhibitor consideration before gynecomastia or cardiovascular estrogen excess develops.

Clinicians should note that DUTCH results in patients on oral progesterone (Prometrium 200 mg nightly) will show PDG values 10 to 20× higher than endogenous luteal-phase values. This is expected and should not prompt dose reduction unless serum progesterone exceeds 40 ng/mL mid-cycle.